CLINICAL_TRIALS
trial_result
· 2013-11-18
Clinical Trial Update: Effect of Namenda on Short Term Memory and Attention in Patients With Mild to Moderate Traumatic Brain Injury [Phase 4]
Summary
Phase 4 trial evaluating memantine (Namenda) for short-term memory and attention in adults with mild to moderate traumatic brain injury; the study was terminate…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Missouri-Columbia | Conditions: Traumatic Brain Injury | Phase 4 | Status: TERMINATED | Results posted: 2013-11-18